Rigenera® Technology

The Science Behind
Revolutionary Results

Our patented Rigenera® Technology enables the extraction and preparation of an autologous micrografting solution called AMT® Triad — composed of progenitor cells, human smart exosomes, and extracellular matrix from your own healthy tissue.

  • Autologous<br>Micrografting

    Autologous
    Micrografting

  • Smart<br>Exosomes

    Smart
    Exosomes

  • No<br>Manipulation

    No
    Manipulation

  • No<br>Manipulation

    No
    Manipulation

What are the benefits?

The AMT® protocol is indicated for patients experiencing androgenetic alopecia at various stages, and can be combined with other treatments for enhanced outcomes.

Find a Certified Clinic

Our Mission

To empower medical professionals worldwide with the most advanced, evidence-based, and minimally invasive regenerative tools for hair restoration unlocking the human body's own innate healing intelligence to restore confidence and quality of life for patients affected by Androgenetic Alopecia.

Regenera Activa

Our Vision

To be the global reference in autologous regenerative medicine setting the scientific standard for safe, effective, and patient-centred hair restoration treatments, and expanding the AMT® platform into new therapeutic areas within regenerative medicine.

Our Journey

Global Presence

  • 2014
    Rigenera® technology patented. First AMT® hair restoration protocols developed.
  • 2015
    Rigenera® Emergency Kit launched. Selected for NATO RAWINTS project.
  • 2016
    Expansion into European, Asian, and South American markets.
  • 2018
    Exponential expansion across Asia
  • 2019
    Contracts established in Middle East and Australia.
  • 2020
    Digital transformation with global webinar programme.
  • 2022
    Participation in the First Barcelona Hair Meeting with Dr. Antonella Tosti.
  • 2024
    Discovery of 55 billion autologous exosomes per session confirmed in landmark study.
  • 2025
    Activa Hair Launch of Rigenera® EVO at IMCAS Paris — the next generation device.
Scientific Advisor

Our KOL Networ

World-leading physicians and researchers who trust, use, and advocate for AMT®
technology in their clinical practice